- Home
- CYCC vs ATCH Comparison
CYCC vs ATCH Comparison
Compare CYCC & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- ATCH
- Stock Information
- Founded
- CYCC 1992
- ATCH 2022
- Country
- CYCC United States
- ATCH United States
- Employees
- CYCC 12
- ATCH N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- ATCH
- Sector
- CYCC Health Care
- ATCH
- Exchange
- CYCC Nasdaq
- ATCH Nasdaq
- Market Cap
- CYCC 2.2M
- ATCH 2.5M
- IPO Year
- CYCC N/A
- ATCH N/A
- Fundamental
- Price
- CYCC $0.36
- ATCH $6.50
- Analyst Decision
- CYCC Strong Buy
- ATCH
- Analyst Count
- CYCC 1
- ATCH 0
- Target Price
- CYCC $11.00
- ATCH N/A
- AVG Volume (30 Days)
- CYCC 6.4M
- ATCH 85.9K
- Earning Date
- CYCC 11-12-2024
- ATCH 02-20-2025
- Dividend Yield
- CYCC N/A
- ATCH N/A
- EPS Growth
- CYCC N/A
- ATCH N/A
- EPS
- CYCC N/A
- ATCH 2.67
- Revenue
- CYCC $74,000.00
- ATCH N/A
- Revenue This Year
- CYCC N/A
- ATCH N/A
- Revenue Next Year
- CYCC $88.68
- ATCH N/A
- P/E Ratio
- CYCC N/A
- ATCH $2.43
- Revenue Growth
- CYCC N/A
- ATCH N/A
- 52 Week Low
- CYCC $0.31
- ATCH $0.12
- 52 Week High
- CYCC $4.00
- ATCH $15.27
- Technical
- Relative Strength Index (RSI)
- CYCC 43.22
- ATCH 33.56
- Support Level
- CYCC $0.34
- ATCH $6.48
- Resistance Level
- CYCC $0.39
- ATCH $9.87
- Average True Range (ATR)
- CYCC 0.08
- ATCH 1.81
- MACD
- CYCC 0.00
- ATCH -0.30
- Stochastic Oscillator
- CYCC 6.30
- ATCH 3.84
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.